Stay updated with breaking news from Pro Dex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pro-Dex (NASDAQ:PDEX – Get Rating) and Cytosorbents (NASDAQ:CTSO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings. Risk and Volatility Pro-Dex has a beta of 0.99, meaning that […]
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 14,200 shares, a growth of 20.3% from the February 28th total of 11,800 shares. Approximately 0.6% of the company’s stock are short sold. Based on an average daily […]
StockNews.com assumed coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report issued on Wednesday morning. The brokerage issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Trading Down 1.2 % Shares of PDEX stock opened at $16.41 on Wednesday. The stock has a market cap of $58.09 million, a price-to-earnings […]
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 14,200 shares, a growth of 20.3% from the February 28th total of 11,800 shares. Approximately 0.6% of the company’s shares are short sold. Based on […]
StockNews.com began coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a research report sent to investors on Wednesday. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Price Performance NASDAQ PDEX opened at $16.41 on Wednesday. The stock has a market capitalization of $58.09 million, a P/E ratio of […]